These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34313752)

  • 1. International Multicenter Validation Study of the SAGIT® Instrument in Acromegaly.
    Giustina A; Bronstein MD; Chanson P; Petersenn S; Casanueva FF; Sert C; Houchard A; Melmed S
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3555-3568. PubMed ID: 34313752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation study.
    Giustina A; Bronstein MD; Chanson P; Petersenn S; Casanueva FF; Sert C; Houchard A; Melmed S
    Pituitary; 2019 Oct; 22(5):476-487. PubMed ID: 31338660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot study.
    Giustina A; Bevan JS; Bronstein MD; Casanueva FF; Chanson P; Petersenn S; Thanh XM; Sert C; Houchard A; Guillemin I; Melmed S;
    Pituitary; 2016 Feb; 19(1):39-49. PubMed ID: 26377024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Applicability of Patient- and Clinician-Reported Outcome Tools in the Management of Patients With Acromegaly.
    Herman R; Goričar K; Janež A; Jensterle M
    Endocr Pract; 2022 Jul; 28(7):678-683. PubMed ID: 35421593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential utility of the SAGIT instrument in the clinical assessment of patients with acromegaly, a large single-centre study.
    Sawicka-Gutaj N; Ziółkowska P; Biczysko A; Erampamoorthy A; Ziemnicka K; Ruchała M
    Sci Rep; 2023 Feb; 13(1):3286. PubMed ID: 36841880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. May the SAGIT® instrument be used as a preoperative prognostic tool in patients with acromegaly?
    Gezer E; Çetinarslan B; Cantürk Z; Selek A; Sözen M; Köksalan D; Bekiroğlu A; Anik I; Ceylan S
    Minerva Endocrinol (Torino); 2022 Oct; ():. PubMed ID: 36285746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum phosphate: Does it more closely reflect the true state of acromegaly?
    Xie T; Tian P; Wu S; Zhang X; Liu T; Gu Y; Sun C; Hu F
    J Clin Neurosci; 2020 Jan; 71():26-31. PubMed ID: 31859176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acromegaly registry of ten different centers in Turkey.
    Keskin Ç; Demir Ö; Karcı AÇ; Berker D; Cantürk Z; Yaylali GF; Topsakal Ş; Ersoy R; Bayram F; Ertörer ME; Bozkırlı E; Haydardedeoğlu F; Dilekçi ENA; Ay SA; Cansu GB; Şahin M; Emral R; Çorapçıoğlu D
    Growth Horm IGF Res; 2020; 53-54():101322. PubMed ID: 32417639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laboratory diagnosis of acromegaly].
    Rosário PW
    Arq Bras Endocrinol Metabol; 2011 Dec; 55(9):723-4. PubMed ID: 22231977
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term endocrinological outcomes of gamma knife radiosurgery in acromegaly patients.
    Uygur MM; Deyneli O; Yavuz DG
    Growth Horm IGF Res; 2020 Dec; 55():101335. PubMed ID: 33190108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of baseline serum phosphorus levels for predicting remission in acromegaly patients.
    Yalin GY; Tanrikulu S; Gul N; Uzum AK; Aral F; Tanakol R
    J Endocrinol Invest; 2017 Aug; 40(8):867-874. PubMed ID: 28357781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly.
    Herman R; Janež A; Goričar K; Rizzo M; Jensterle M
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556914
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of adjustments to the diagnostic criteria for biochemical remission in surgically treated patients with acromegaly.
    Kousoula K; Farmaki K; Skoglund T; Olsson DS; Johannsson G; Trimpou P; Ragnarsson O
    Growth Horm IGF Res; 2017 Oct; 36():16-21. PubMed ID: 28846862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report.
    Wijayaratne DR; Arambewela MH; Dalugama C; Wijesundera D; Somasundaram N; Katulanda P
    J Med Case Rep; 2015 Oct; 9():241. PubMed ID: 26514337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of insulin-like growth factor-1 and growth hormone in the mortality of patients with acromegaly after trans-sphenoidal surgery.
    Wu TE; Lin HD; Lu RA; Wang ML; Chen RL; Chen HS
    Growth Horm IGF Res; 2010 Dec; 20(6):411-5. PubMed ID: 20943425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acromegaly: reducing diagnostic delay].
    Giustina A
    Recenti Prog Med; 2016 Aug; 107(8):450-1. PubMed ID: 27571562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of treatment success in patients with acromegaly: the value of serum insulin-like growth factor binding protein-3 and serum leptin measurements in comparison to plasma insulin-like growth factor I determination.
    Páramo C; Fluiters E; de la Fuente J; Andrade A; García-Mayor RV
    Metabolism; 2001 Sep; 50(9):1117-21. PubMed ID: 11555849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Alpha Klotho in Acromegaly: Comparison With Traditional Markers of Disease Activity.
    Schweizer JROL; Schilbach K; Haenelt M; Giannetti AV; Bizzi MF; Soares BS; Paulino E; Schopohl J; Störmann S; Ribeiro-Oliveira A; Bidlingmaier M
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2887-e2899. PubMed ID: 33864468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the Role of Insulin-like Growth Factor-1 Measurement After Surgical Treatment of Acromegaly.
    Jung IH; Choi S; Ku CR; Lee SG; Lee EJ; Kim SH; Kim EH
    J Clin Endocrinol Metab; 2021 Jun; 106(7):e2589-e2599. PubMed ID: 33738470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.